Skip to content
Boehringer Ingelheim
-
Boehringer Ingelheim joins forces with Salipro Biotech to tackle “undruggable” targets
As part of the agreement, Boehringer will undertake structural and biophysical studies, including cryo-electron microscopy, to pinpoint promising drug candidates.
-
